ArticlePublic health in practice (Oxford, England)2022

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine.

Nawfal R Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.